In 2000, the American Cancer Society inaugurated a yearly reporton guidelines for cancer detection. The latest update, publishedin 2005,1 is identical to the previous versions in its recommendationregarding screening techniques that have not changed in decades.An especially striking feature of the recommendations is thecontinued absence of any mention of laboratory tests that shouldbe readily available, considering the explosion of knowledgein cancer biology, molecular biology, genetics, and immunology.The scientific literature is full of articles heralding thepotential of genomics,2 proteomics,3 metabolomics,4 and other"omics" for the improvement of the diagnosis, treatment, andprognosis . . . [Full Text of this Article]
Source Information
From the Department of Immunology, University of Pittsburgh School of Medicine, and the University of Pittsburgh Cancer Institute both in Pittsburgh.
This article has been cited by other articles:
Pereira-Faca, S. R., Kuick, R., Puravs, E., Zhang, Q., Krasnoselsky, A. L., Phanstiel, D., Qiu, J., Misek, D. E., Hinderer, R., Tammemagi, M., Landi, M. T., Caporaso, N., Pfeiffer, R., Edelstein, C., Goodman, G., Barnett, M., Thornquist, M., Brenner, D., Hanash, S. M.
(2007). Identification of 14-3-3{theta} as an Antigen that Induces a Humoral Response in Lung Cancer. Cancer Res.
67: 12000-12006
[Abstract][Full Text]
Caron, M., Choquet-Kastylevsky, G., Joubert-Caron, R.
(2007). Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery. Mol. Cell. Proteomics
6: 1115-1122
[Abstract][Full Text]